Source-grounded facts extracted from CVS HEALTH Corp's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
CVS HEALTH Corp reported the three months ended March 31, 2026 results: revenue $100.4 billion, net income $2,957, EPS $2.30. Guidance raised.
“CVS HEALTH CORPORATION REPORTS STRONG FIRST QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE • First quarter total revenues increased to $100.4 billion, up 6.2% year-over-year • First quarter GAAP diluted EPS of $2.30 and Adjusted EPS of $2.57”
Thomas F. Cowhey changed role as Executive Vice President and Chief Financial Officer at CVS HEALTH Corp.
“On April 7, 2025, the Board of Directors of the Company also determined that Thomas F. Cowhey, currently the Executive Vice President and Chief Financial Officer of CVS Health, will cease to serve as Executive Vice President and Chief Financial Officer of CVS Health as of the Effective Date.”
Brian O. Newman was appointed as Executive Vice President and Chief Financial Officer at CVS HEALTH Corp.
“On April 7, 2025, the Board of Directors of CVS Health Corporation (the “Company” or “CVS Health”) appointed Brian O. Newman to serve as Executive Vice President and Chief Financial Officer of CVS Health, effective May 12, 2025 (the “Effective Date”).”
Doug Shulman was appointed as Director at CVS HEALTH Corp.
“On November 17, 2024, Ms. Norwalk, Mr. Robbins, Mr. Sansone and Mr. Shulman were appointed to the Board.”
Guy Sansone was appointed as Director at CVS HEALTH Corp.
“On November 17, 2024, Ms. Norwalk, Mr. Robbins, Mr. Sansone and Mr. Shulman were appointed to the Board.”
Larry Robbins was appointed as Director at CVS HEALTH Corp.
“On November 17, 2024, Ms. Norwalk, Mr. Robbins, Mr. Sansone and Mr. Shulman were appointed to the Board.”
Leslie Norwalk was appointed as Director at CVS HEALTH Corp.
“On November 17, 2024, Ms. Norwalk, Mr. Robbins, Mr. Sansone and Mr. Shulman were appointed to the Board.”
Prem S. Shah was appointed as Executive Vice President and Group President at CVS HEALTH Corp.
“On November 6, 2024, CVS Health Corporation (the “ Company ”) appointed Prem S. Shah as Executive Vice President and Group President, a newly created position within the Company.”
Roger N. Farah was appointed as Executive Chairman of the Board at CVS HEALTH Corp.
“Effective October 17, 2024, the Board has also appointed current Chairman Roger N. Farah as Executive Chairman of the Board.”
Karen S. Lynch resigned as President and Chief Executive Officer at CVS HEALTH Corp.
“Karen S. Lynch ceased to serve as President and Chief Executive Officer of the Company and resigned as a member of the Board on the same day.”
J. David Joyner was appointed as President and Chief Executive Officer at CVS HEALTH Corp.
“the Board of Directors (the “ Board ”) of the Company appointed J. David Joyner as President and Chief Executive Officer of the Company, effective as of October 17, 2024.”
CVS HEALTH Corp reported full-year 2024 results: EPS Revised GAAP diluted EPS guidance to at least $5.64 from at least $7.06. Guidance lowered.
“Revised GAAP diluted EPS guidance to at least $5.64 from at least $7.06”
CVS HEALTH Corp reported the three months ended March 31, 2024 results: revenue $88,437, EPS $0.88.
“results for the three months ended March 31, 2024. Financial Results Summary Three Months Ended March 31, In millions, except per share amounts 2024 2023 Change Total revenues $ 88,437 $ 85,278 $ 3,159 Operating income 2,271 3,446 (1,175) Adjusted operating income (1) 2,957 4,370 (1,413) Diluted earnings per share $ 0.88 $ 1.65 $ (0.77) Adjusted EPS (2) $ 1.31 $”
CVS HEALTH Corp reported three months and year ended December 31, 2023 results: revenue $93.8 billion, EPS GAAP diluted EPS of $1.58 and Adjusted EPS of $2.12. Guidance lowered.
“(NYSE: CVS) today announced operating results for the three months and year ended December 31, 2023. FOURTH QUARTER HIGHLIGHTS KEY FINANCIAL DATA • Total revenues increased to $93.8 billion, up 11.9% compared to prior year • GAAP diluted EPS of $1.58 and Adjusted EPS of $2.12 FULL-YEAR HIGHLIGHTS • Total revenues increased to $357.8 billion, up 10.9% compared to”
Shawn M. Guertin departed as Executive Vice President, Chief Financial Officer and President of Health Services at CVS HEALTH Corp.
“On January 5, 2024, CVS Health also announced that Shawn M. Guertin, who, as previously disclosed, was on a personal leave of absence since October 13, 2023, will step down from his role as CVS Health’s Executive Vice President, Chief Financial Officer and President of Health Services due to family health reasons, effective immediately.”
Thomas F. Cowhey was appointed as Executive Vice President and Chief Financial Officer at CVS HEALTH Corp.
“The Board of Directors (the “Board”) of CVS Health appointed Thomas F. Cowhey to serve as CVS Health’s Executive Vice President and Chief Financial Officer, effective January 5, 2024.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.